Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MND-2119 Clinical Pharmacology Study
jRCT2031210362Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of MND-2119 (4 arms), sponsored by Mochida Pharmaceutical Co., Ltd. Primary endpoints: Fatty acid composition of plasma, Fatty acid composition of blood cells and 2 more. Started Oct 2021; status: completed.
02
Drugs
MND-2119
Beyond the preview
Go deeper on jRCT2031210362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210362.